Introduction
A wide variety of lesions have been reported in the different studies of epilepsy in the literature; though the question is still raised if these observed lesions are the cause or the consequence of seizures. The lesions that might play a role in the onset, maintenance and progression of pharmacoresistance of epileptic seizures, as well as the lesions that might results in are not yet well predicted and comprehensible.
Histopathological findings
A confusing array of histopathological findings was reported in the studies of temporal lobe and hippocampus in chronic pharmacoresistant temporal epilepsy, in the literature. We would like to suggest that these findings could be grouped in certain categories:
Malformations
Many types of malformations were reported in epileptic series; these included the following: (Wolf et al, 1993 Prayson et al, 1996; Volk et al, 1997; Armstrong et al, 2007; Al Khani & Assaad, 2008) :
Subependymal nodular cortical heterotopias and band heterotopias [double cortex]
Congenital lesions composed of heterotopic cortical tissue in a periventricular subependymal location; they are closely associated with epilepsy (d'Orsi, 2004; Armstrong et al, 2007 ) (see fig. 1-2) 
Cortical malformations
They include lissencephaly (smooth or nearly smooth cortical surface), hemimegalencephaly (enlarged hemisphere) and pachygyria-polymicrogyria (Sisodiya et al, 2004; Armstrong et al, 2007) . Gyral fusion and abnormal elongation of a sulcus are other reported findings (see fig.3 ) (Al Khani & Assaad, 2008) . It is suggested that cortical malformations can both form epileptogenic foci and alter brain development in a manner that causes a diffuse hyperexcitability of the cortical network (chevaussus et al, 1999) . 
Neuronal and glioneuronal malformations
These malformations are composed of foci of havardous atypical neurons and Glioneuronal tissue. They overlap with neuronal and neuronal-glial tumors (Wolf et al, 1993 prayson et al, 1996; Volk et al, 1997; Al Khani & Assaad, 2008) , (see paragraph 2.4)
Microdysgenesis
This includes the following lesions of abnormal migration (Armstrong et al, 2007) : 1. Ectopic neurons in the white matter in greater than normal numbers 2. Gray matter heterotopias: foci of displaced "gray matter" composed of neurons, glia, and neuropil characteristics. 3. Hamartia that are microscopic collections of small, round "oligodendroglia-like" cells.
They may be observed in the cortex or in the white matter and have some staining characteristics of immature neurons 4. Perivascular glial nuclei refer to the presence of chains of bare glial nuclei in the white matter 5. Neuronal clusters
Vascular malformations
Vascular malformations are known to cause seizures; notably arteriovenous malformations. All vascular tumors of the central nervous system are considered as malformative lesions (Louis et al, 2007) .
Cortical dysplasia/dysgenesis
The histopathology of "cortical dysplasia" or "cortical dysgenesis" as described by the authors (Taylor et al, 1971; Prayson et al, 1995 Prayson et al, -1996 Frater et al, 2000; Wang et al, 2006; Armstrong et al, 2007; Bernasconi et al, 2011) includes a variety of structural changes which could be focal, multifocal, or diffuse, resulting in changes in the neuronal network inciting seizures attacks: neuronal migration abnormalities, diffuse architectural disorganization of the cortex with cortical laminar disruption, gyral fusion, clusters of atypical neurons and glial cells within the cortex, malalignment of neurons, neuronal cytomegaly, increased numbers of molecular layer neurons, the presence of large neurons displaying a pyramidal or round shape, ballooned cells, and a high concentration of neurofilaments in giant neurons and of glial intermediate filaments in ballooned cells, evoking disruption of cell differentiation and maturation and an impairment of synaptogenesis (Garbelli et al, 1999) . The term "cortical dysgenesis or disorganization" might be more appropriate. Classification schemes were described; the widely adopted is that described by palmini et al. This classification distinguished two types of cortical dysplasia based of the presence or absence of dysmorphic neurons or balloon cells, as follows (palmini et al, 2004): Type I: IA: Isolated architectural abnormalities, usually laminar or columnar disorganization, but no dysmorphic neurons IB: Architectural abnormalities, giant cells or immature neurons can be found Type II: IIA: Architectural abnormalities with dysmorphic cells are found, but no balloon cells IIB: Architectural abnormalities with both dysmorphic cells and balloon cells Changes of the above described "cortical dysplasia" are observed in all cases of epilepsy in some studied series (Al Khani & Assaad, 2008) ( fig 3&4) . Irregular brain surface and irregular cortical thickness were also described; that might be the consequence of neuronal reorganization associated with glial cell reaction. Cortical dysgenesis might begin as an in utero migrational abnormality (Sprifeafico et al, 1998) so some authors put these lesions under the category of malformations (Armstrong et al, 2007) , or as an acquired cortical dysplasia in response to perinatal brain damage (Marin-Padilla et al, 1999) . This alteration becomes an ongoing process that affects the structural and functional differentiation of neurons, synaptic profiles, fiber distribution, glial elements, and vasculature. Cortical dysplasia/disorganization becomes worse with the recurrence of seizures and exacerbates neuronal damage.
Signs of neuronal injury, neuronal lysis, apoptosis and neuronal loss
Neuronal damage and loss have been well documented in studies of epilepsy. Neuron loss is mainly observed in CA2& CA1 sectors of ammon horn ( fig 5) and it might be observed in the other sectors in the advanced cases; it is found to be followed by axonal and mossy fibers sprouting and reorganizing (El Bahh et al, 1999; Armsrong et al, 2007) . Neuron injury and loss was evident in many series, affecting especially the pyramidal cells in the cortex and the granular cells in the dentate gyrus (dentate nucleus) (Proper et al, 2000 ; Al Khani and Assaad, 2008) ( fig.6-9 ). The survived cells showed variability in size and shape, edema and vacuolization, and disorganization. Unexplained PAS + material was also described in some observations in the cytoplasm of the injured neurons. Neuronal lysis and apoptosis were noted in our study adjacent to injured neurons. Neuronal damage especially affecting these neurons was well documented in animal experimental models. (Bouilleret et al, 2000) www.intechopen.com The loss of a critical number of interneurons in the dentate gyrus was suggested as a possible cause of seizure initiation (Fritschy et al, 1999) It was suggested that childhood seizures can damage or alter the postnatally developing granule cells of the human hippocampus, and that early neuron loss and aberrant axon circuits may contribute to chronic hippocampal seizures (Mathern et al, 1996) . The role of apoptosis-related genes and the activation of the programmed death pathway were well documented by some authors, explaining that neuronal loss (Uysal et al, 2003; d'Orsi et al, 2004; Niquet et al, 2004; ) . Apoptotic neurons were noted beside neuron lysis; these two forms of cell death in histopathological findings might contribute to neuron loss (Becker et al, 1999; Al Khani & Assaad 2008) (fig 7) . 
Tumors and hamartomatous tumors
Some tumors are known to be frequently associated with epilepsy, such as dysembryoplastic neuroepithelial tumors (DNETs), ganglioneuromas and gangliogliomas, which can be either bilateral or multifocal (Barbosa et al, 1999; Whittle et al, 1999; Rosemberg et al, 1998; Al Khani and Assaad, 2008; Louis et al, 2007) (fig. 10 ). The hamartomatous origin of these tumors is suggested by some authors, as they are composed of mature multiple cell types (Gyure et al, 2000; Louis et al, 2007) Other low-grade tumors were reported in some cases of pharmacoresistant temporal epilepsy, such as xanthoastrocytomas ( fig.11 ), low-grade astrocytomas, oligodendrogliomas, oligoastrocytomas, vascular tumors (Oda et al, 1998) and mixed or composite tumors (Hirose et al, 1998) Their incidences varies widely from one series to another; they were found with high percentages in some series, where most of the glioneuronal tumors were bifocal, multifocal, or associated with each other, with transitional zones or "composite tumors" as described by some other authors Al Khani & Assaad, 2008) ( fig.12 ). The juxtaposition of these tumors, and the transition between DNETs, gangliogliomas, or hamartomatous glioneuronal lesions might support the hypothesis that all these tumors are of hamartomatous origin. The relationship and the transition between these lesions have also been reported other authors (Hirose et al, 1998; Moreno et al, 2001) .
Inflammation
Different causes of inflammatory changes are described in the cases of epilepsy; the most famous is Rasmussen's encephalitis that is frequently reported in series of epilepsy (Frater et al, 2000; Prayson et al, 1999; Al Khani & Assaad, 2008) It is defined by lymphoid infiltration of the cerebrocortical perivascular compartment and neuropil, microglial nodule formation, astrogliosis, and variable neuronal loss. Cytomegalovirus and herpes virus HSV1 are found in some cases. (Jay et al, 1995) . Inflammation caused by protozoan, parasites, and brain abscess was sometimes accompanied by seizures (Armstrong et al, 2007) . Chronic encephalitis without evidence of pathogenic agent is sometimes reported Al Khani & Assaad, 2008) .
Ischemic and hemorrhagic disorders
Ischemic changes and infarct were reported in some series; this might results in severe atrophy ( fig. 13 ). Abnormal blood supply was noted by some authors (Al Khani & Assaad, 2008; Fratel et al, 2000; Li et al, 1999; Prayson et al, 1999; Bernhardt et al, 2009 ). Hematomas were associated in some series with chronic epilepsy (Hisada et al, 1999; Al Khani & Assad, 2008) . Fig. 10 . Dysembryoplastic neuroepithelial tumor is a common tumor found in epileptic cases. Fig. 11 . Xanthoastrocytoma is a rare low-grade glial tumor that can constitute an epileptogenic focus. 
Metabolic disorders, vacuolization, and cystic changes
This was represented by vacuolar degeneration of neurons and glial cells ( fig. 14) , and cystic changes of the cortical, subcortical or glial tissue, reaching many centimeters in some cases where they could be detected on the macroscopic examination of the cut section; otherwise, they were microscopic findings. Cystic changes of the nervous tissue were constant observations in some refractory epilepsy series; thought they are considered as non-specific findings. These cysts were not alcianophilic, PAS stain was also negative (Al Khani & Assaad, 2008) . Progressive metabolic changes were noted, occurring during the development of hippocampal sclerosis in a model of mesial temporal lobe epilepsy (Bouilleret et al, 2000) The progress of metabolic or pathologic abnormalities of temporal lobe epilepsy may not be altered by adequate seizure control, as the presence of an epileptogenic focus might be associated with progressive neuronal injury even in clinically well-controlled patients (Spanaki et al, 2000) This might explain the exacerbation of neuronal damage and nervous tissue injuries with all the pathological changes constantly observed. Some authors found that hippocampal cell loss results in decreased efferent synaptic activity and neuronal activity in the thalamus and basal ganglia, and subcortical hypometabolism, which may reinforce the epileptogenic potential of the mesial temporal lobe discharge (Dlugos et al, 1999) . In a studied series of refractory epilepsy, signs of metabolic disorders were noted in all of the cases (Al Khani & Assaad, 2008) . 
Northern epilepsy
Other authors found intraneuronal accumulation of cytoplasmic autofluorescent granules in which is called as northern epilepsy (Herva et al, 2000) .
Sclerosis/gliosis
Gliosis is noted in all of the reported series of epilepsy with various degrees. Some investigators view hippocampal sclerosis as the primary cause of temporal lobe epilepsy, whereas others interpret the changes to be the result of chronic seizure activity. The macroscopic and radiological term of hippocampal sclerosis is interpreted, on histopathological examination, as astrogliosis associated with neuronal loss (Rushing et al, 1997; Prayson et al, 1999) . Astrogliosis or oligoastrogliosis (fig 15) was observed, in varying degrees, in the temporal lobe and hippocampus in all cases of drug resistant epilepsy in some series (Al Khani & Assaad, 2008) , even in patients with no remarkable abnormalities on MRI in the temporal lobe, but with an irregular hippocampal signal on MRI. Cortical gliosis, especially subpial gliosis (fig 4) was always accompanied by advanced cortical dysplasia; this leads to believe that progressive gliosis might be a reactive process induced by neuronal injury and loss, seizure attacks, and metabolic disorders. Sclerosis/gliosis might be considered as the end-stage of the all modifications. Focal oligogliosis is sometimes noted (fig 16) . 
Combinations of lesions: "Dual pathology"
Some authors mentioned that seizure attacks require dual pathology, as several observations revealed combinations of lesions (Jay et al, 1994; Oda et al, 1998; Juhsz et al, 1999; Li et al, 1999; Prayson et al, 2010) ; for example, the coexistence of brain tumors and cortical dysplasia, neuronal migration disorders and low grade gliomas, lesions having both neoplastic and malformed foci, extrahippocampal lesion plus hippocampal atrophy, and coexistence of hippocampal sclerosis and a potentially epileptogenic cortical lesion. It was also reported that bilateral hippocampal atrophy was found frequently in patients with temporal lobe developmental malformations, and that the presence of bilateral amygdala or amygdalo-hippocampal atrophy was associated with a higher risk of seizure recurrence (Kuzniescky et al, 1999) . The multifocality of malformative lesions was well reported by some authors Moreno et al, 2001; Armstrong et al, 2007) . In our series (Al Khani & Assaad, 2008) dual pathology was well documented as tumors were always present in association with other changes, that were almost always seen: cortical dysplasia, astrogliosis, cystic changes, and neuron injury and loss. The presence of bifocal or multifocal tumors and/or hamartomas was another observation to be noted.
Conclusion
A wide variety of lesions is documented in histopathological study of the temporal lobe and the hippocampus in temporal epilepsy, especially pharmacoresistant epilepsy. Some lesions were constantly present; cortical disorganization, neuron injury and loss, and gliosis. A presumable epileptogenic focus as hamartoma or tumoral lesion is frequently observed. Multiplicity and multifocality of lesions are well documented, reinforcing the hypothesis that the presence of an epileptogenic focus provokes a process of progressive damage of the nervous tissue. The good understanding of these processes and their sequencing, especially those leading to neuron death and loss, might contribute in the prevention of progression of epileptic seizure and the damage of nervous tissue in previously susceptible patients.
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